Not yet taking people in Ausztria1. fázis
A randomized, placebo-controlled, double-blind, single-ascending-dose, Phase 1a/b study to assess the safety, pharmacokinetics, pharmacodynamics, and immunogenicity of intravenous NTR-641 in healthy adults and patients with acute ischemic stroke
Key facts
- Where
- Vienna, AusztriaSee the 2 sites
- Phase
- 1. fázis
Where in Ausztria
- Krankenhaus Der Barmherzigen Brueder WienVienna, AusztriaToborzás még nem indult
- Medical University of ViennaVienna, AusztriaToborzás még nem indult
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Neutrolis Inc.
- Trial code
- EU 2024-512196-12-00
- Record updated
- 2025. július 21.